🔎 Trials Near Me

Beranda › PPOK › Maryland › Baltimore

Uji klinis PPOK di Baltimore, MD

14 studi untuk PPOK mencari peserta di lokasi sekitar Baltimore (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Menerima pesertaFase 3
  • Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190222

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Menerima pesertaFase 4
  • Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Menerima pesertaFase 2
  • Research Site, Baltimore
  • Research Site, Baltimore
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Menerima pesertaFase 2
  • Johns Hopkins University, Baltimore
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Menerima pesertaFase 3
  • Research Site, Baltimore
  • Research Site, Rosedale · 6 mi jauhnya
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Menerima pesertaFase 3
  • Research Site, Baltimore
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06883305

STRIVE Post-Market Registry Study

Menerima pesertaStudi observasional
  • University of Maryland, Baltimore
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT04302272

Multi-Center Clean Air Randomized Controlled Trial in COPD

Menerima pesertaFase 3
  • University of Maryland, Baltimore
  • Johns Hopkins, Baltimore
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06376994

SPIROMICS Study of Early COPD Progression (SOURCE)

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Johns Hopkins Bayview Medical Center, Baltimore
Usia 30 hingga 55 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05033990

OMEGA - Dietary Intervention - COPD Trial

Menerima peserta
  • Johns Hopkins Bayview Campus, Baltimore
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 16 Mar 2026 · NCT05297279

Trial to Determine Effective Aspirin Dose in COPD

Menerima pesertaFase 3
  • Johns Hopkins Bayview Medical Center, Baltimore
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 16 Mar 2026 · NCT05265299

Effectiveness of the WearME System for COPD Severity and Respiratory Function

Menerima pesertaStudi observasional
  • Johns Hopkins, Baltimore
Usia 21 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT06751537

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Menerima pesertaStudi observasional
  • Ascension St. Agnes Hospital, Baltimore
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Menerima peserta
  • University of Maryland - Baltimore, Baltimore
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2025 · NCT05204888

Uji klinis PPOK di kota lain

Studi lain di Baltimore

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.